Chair of the Board · Candel Therapeutics, Inc. (CADL)

Paul B. Manning director compensation at Candel Therapeutics: $131K

Fiscal year 2025 director compensation for Paul B. Manning at Candel Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Paul B. Manning’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Paul B. Manning and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Candel Therapeutics Director Compensation Table · all 4 fiscal years held
In US dollars, as Candel Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$70,000$0$60,546$0$130,546
FY2024$70,000$0$68,405—$138,405
FY2023$70,000$0$13,186—$83,186
FY2021$16,667—$0—$16,667

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Candel Therapeutics, Inc. DEF 14A filed April 29, 2026, accession 0001193125-26-191506, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Candel Therapeutics, Inc. filed document, accession 0001193125-26-191506. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Get the Candel Therapeutics Board Governance Report

$130,546 Paul B. Manning, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Candel Therapeutics pays directors a $35,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation

The rest of the Candel Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Christopher MartellIndependent Director$114,546
Diem Nguyen, Ph.D. M.B.AIndependent Director$104,310
Edward J. Benz Jr., M.DIndependent Director$103,546
Gary J. Nabel, M.D., Ph.DIndependent Director$99,546
Joseph C. Papa, R.Ph., M.B.AIndependent Director$101,810
Maha Radhakrishnan, M.DIndependent Director$158,346
Nicoletta Loggia, Ph.D., R.PhIndependent Director$107,019
Renee GaetaIndependent Director$103,046

The full Candel Therapeutics compensation record

free company brief

This page is one director within Candel Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order CADL

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report